This Week in Biotech
Motley Fool
Breo Ellipta gains US approval for the treatment of COPD
Yahoo/PR Newswire
FDA approves Breo Ellipta to treat chronic obstructive pulmonary disease
Yahoo/Fly on the Wall
3 Biotech Companies Ripe for a Takeover
Motley Fool
This Week in Biotech
Motley Fool

